Well summarized! @TheExecutive
@Gdubb8899 lots of history here. Revenues are out of this world for the price of admission. Trust issues with the CEO is hurting it. Growth doesn’t reflect the pps but convertible notes from last year is suppressing the price. Best fiscal analysis buy in the OTC. Audits are underway and OTCQB is a month away. My considerations from here is a 10 bagger before 2022 but who the fuck knows right?
View original message
4